Investing in Life Sciences sectors like Healthcare and Biotechnology.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Casdin Capital

Casdin Capital is a company. Casdin Capital has completed 1 acquisition, including Singular Genomics. Casdin Capital offers products and services including Investment Services and Venture Funding.

  • Sectors
    Healthcare
    Agriculture
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Casdin Capital
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Agriculture → Livestock & Animal Nutrition Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Casdin Capital

Casdin Capital offers a comprehensive portfolio of products and services, including Investment Services and Venture Funding.

Product name locked
Category locked
Primary

Investing is conducted in healthcare innovations and molecular medicine to support paradigm shifts in disease identification and treatment

Product name locked
Category locked
Locked

Funding is provided for biotechnology and synthetic biology companies to advance tools, diagnostics, and therapies

People of Casdin Capital

Headcount 10-50
Employee Profiles 10
Board Members and Advisors 9
Employee Profiles
People
Eli Casdin
Chief Investment Officer & Founder
People
Randy White
Director of Business Development & Investor Relations
People
Scott Bryan
Head of Technology
People
Caroline Hegarty
Executive Assistant

Unlock access to complete

Board Members and Advisors
people
Alex Parker
Advisor
people
William G. Kaelin
Advisor
people
Alan Huang
Advisor
people
Kevin O’brien
Advisor

Unlock access to complete

Funding Insights of Casdin Capital

Premium access

Detailed funding history for Casdin Capital

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Casdin Capital

Casdin Capital has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Singular Genomics.

Investments
Premium access

Investment portfolio details for Casdin Capital

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Next-generation gene sequencing and multi-omics technologies are provided.
Locked Locked 2016 Locked
Premium access

Complete acquisition details for Casdin Capital

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Casdin Capital

Premium access

Detailed financials for Casdin Capital

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Casdin Capital Comparisons

Casdin Capital Primary company
Description
Investing in Life Sciences sectors like Healthcare and Biote...
Location
-
Founded Year
-
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Casdin Capital

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Casdin Capital

Premium access

Detailed competitors of Casdin Capital

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Casdin Capital

Premium access

Complete news archive for Casdin Capital

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Casdin Capital

Casdin Capital is identified as an investor in the dynamic Life Sciences field, covering Healthcare, Biotechnology, Synthetic Biology, and Technology. Positions are built by partnering with companies that leverage molecular information for innovations in diagnostics and therapies. Emphasis is placed on patience, persistence, and values such as excellence and integrity, while opportunities are explored in areas like gene therapies and data platforms. The firm is noted for its expertise in navigating ethical and scientific challenges, contributing to advancements that address global demands.

Casdin Capital offers Investment Services and Venture Funding.

Casdin Capital has made 1 acquisition, including Singular Genomics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available